Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Sucampo suspends tacrolimus eye drops development program

June 29, 2005

Duska acquires P2 receptor-based technology to treat glaucoma

June 21, 2005

Enzo acquires rights to drug candidate for treating uveitis

June 16, 2005

Potassium channel blockers for glaucoma, etc., emerge from Merck & Co. research

June 14, 2005

Target enrollment reached in phase II wet AMD study of Evizon

June 13, 2005

Phase IIb study of NP-50301 for dry eye syndrome completes enrollment

June 9, 2005

Inspire submits NDA amendment for diquafosol for dry eye

June 3, 2005

First phase I study of OT-551 for cataracts meets all safety and comfort endpoints

May 30, 2005

Alcon receives approvable letter from FDA for Retaane AMD treatment

May 26, 2005

Isis and Pfizer form ophthalmic antisense drug discovery collaboration

May 26, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...